Founded by Mary Ann Liebert in 1980, Mary Ann Liebert, Inc. is a leading independent publisher of scientific, technical, and medical content, known worldwide for its prescience and establishment of authoritative peer-reviewed journals, books, and trade publications in cutting-edge fields such as biotechnology, biomedical research, medicine and surgery, public health research and policy, technology and engineering, law, environmental research and policy, and other specialized disciplines. The company publishes over 90 peer-reviewed journals, leading trade magazines, and specialized newsletters, in addition to society membership management and conferences.
Driven by her visionary passion and ceaseless curiosity, Mary Ann Liebert identifies and nurtures critical topics and cutting-edge fields by creating first-to-market, specialized publications that play a vital role in advancing research and facilitating collaboration in academia, industry, and government. The company is deeply committed to ensuring the highest quality content and is able to invest for the long-term, supporting publications in emerging markets through to maturity.
The company’s flagship publication, Genetic Engineering & Biotechnology News (GEN), was launched in 1980, the very first publication of its kind for the field of biotechnology. Today, GEN is the most widely read and highly regarded publication in the field, delivering cutting-edge news and analysis of the technologies, applications, and trends that are driving the future of biotechnology. GEN has been at the forefront of the field since the birth of biotech, maintaining unrivaled integrity, influence, and expertise that plays a pivotal role in driving the productivity and growth of the industry.
The company has published many “firsts” in the market, including AIDS Research and Human Retroviruses, Human Gene Therapy, LGBT Health, and, most recently, The CRISPR Journal.
Mary Ann Liebert, Inc. provides fast and flexible models for authors, libraries, and institutions that enable rapid dissemination and high visibility of published content. The company’s mission is to advance research and development, foster collaborations that enable best therapeutic options, and, ultimately, to improve patient care.
More than just a publisher, Mary Ann Liebert, Inc. collaborates effectively with corporations, educational institutions, nonprofit foundations, and other enterprises in a broad array of extended capabilities that include custom publications, conferences, webinars, association management, videos, and newsletters. These resources play a pivotal role for corporations, associations, and institutions to advance their own goals.
Browse our publications, explore the content of our established journals, and learn more about our extensive capabilities. As always, Mary Ann welcomes your feedback and input, and is committed to continuing to meet the needs of the members of academia, government, and industry—in the public and private sectors—around the world.
Mary Ann Liebert…
- identifies and nurtures critical topics and cutting-edge fields
- insists on quality and credibility of content
- invests in products for the long term
- innovates technological advances to improve access to scholarly communication
- provides unique author services to ensure research impact
- creates and supports flexible models for authors, libraries, and institutions